BlossomHill Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for BlossomHill Therapeutics

Access the complete profile.

BlossomHill Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address	3525 John Hopkins Court Suite 100 San Diego, CA 92121

Note: Revenues for privately held companies are statistical evaluations.


BlossomHill Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • BlossomHill Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • BlossomHill Therapeutics is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

BlossomHill Therapeutics Annual Revenue and Growth Rate

BlossomHill Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: BlossomHill Therapeutics's revenues are gauged from an analysis of company filings.

BlossomHill Therapeutics's Income Statement (based on Industry Averages)

BlossomHill Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

BlossomHill Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 2, 2024	44	89%	$100 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that BlossomHill Therapeutics is developing and marketing. BlossomHill Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
OMNI-EGFR pharmaceutical products	01/16/2024
BLOSSOMHILL THERAPEUTICS Research and development in the pharmaceutical and biotechnology fields	06/29/2020

See all trademarks and details in the Full Report.

Market Share of BlossomHill Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as BlossomHill Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to BlossomHill Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MEDVANTX	San Diego, CA	100
STAR MANU	San Diego, CA	13
BLOSSOMHILL THERAPEUTICS	San Diego, CA	13
PHARMACARE US	San Diego, CA	7
LASSOGEN	San Diego, CA	6
BELOTECA	San Diego, CA	4

Future Competition: BlossomHill Therapeutics's Fastest Growing Competitors

These companies are in the same general field as BlossomHill Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)